Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities.
read more
Monday, December 06, 2021
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has won, in collaboration with BioNTech and Pfizer, the Clinical Advance of the Year category - ...
read more
CluePoints, a provider of quality management solutions for clinical trials, launched a new Post-COVID Trial Assurance Solution. The solution offers study teams the opportunity to assess the quality of their data within a defined timeline and with ...
read more
Thursday, December 05, 2019
CluePoints has been awarded best technological development in clinical trials in the 2019 Scrip Awards.
read more
CluePoints has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.
read more
Monday, September 09, 2019
CMAB Biopharma announced a positive opinion in an external European quality audit conducted by Parexel International.
read more
Wednesday, October 16, 2019
CMAB Biopharma and BJ Bioscience announced a strategic agreement for the development and manufacturing of a Bi-functional Antibody as the first step in an exclusive collaboration.
read more
Monday, December 09, 2019
CMAB Biopharma and Shenzhen Fapon Biopharma announced a comprehensive strategic agreement for the development and manufacturing of an undisclosed biologic drug project.
read more
Wednesday, September 04, 2019
CMAB Biopharma and Kintor announced a comprehensive strategic cooperation agreement for the development and manufacturing of ALK-1 monoclonal antibody (mAb).
read more
Thursday, February 18, 2016
CMC Biologics A/S and IDT Biologika GmbH have announced the formation of a strategic collaboration to provide a complete and efficient solution for the manufacture of antibody drug conjugates (ADCs).
read more
CMC Biologics, Inc., a global leader in process development and contract
manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company
focused on discovering and developing innovative monoclonal antibody-based ...
read more
CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based ...
read more
Friday, December 20, 2013
CMC Biologics and OncoSynergy announced today that the two
companies entered into an agreement for cell-line development, process development,
analytical development and manufacturing of non-GMP material to enable early toxicology
testing and cGMP...
read more
Tuesday, December 29, 2015
CMC Biologics, Inc. today announced that they have entered into an agreement with Immunocore Limited, a leading UK-based biotechnology company focused on developing new treatments for cancer, viral infections and autoimmune diseases, for the process ...
read more
CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, today announced that it has hired Patricio E. Massera to serve as the Company’s new General Manager for its ...
read more